Cantitate/Preț
Produs

The Prognosis of Metastatic Gastrointestinal Cancer

Autor Giuseppe A. Colloca, Antonella Venturino
en Limba Engleză Paperback – oct 2024
Survival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists' estimates of patients' predicted overall survival in metastatic cancer are imprecise. The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 58235 lei  3-5 săpt. +2204 lei  6-12 zile
  CRC Press – oct 2024 58235 lei  3-5 săpt. +2204 lei  6-12 zile
Hardback (1) 129329 lei  6-8 săpt.
  CRC Press – oct 2024 129329 lei  6-8 săpt.

Preț: 58235 lei

Preț vechi: 61300 lei
-5% Nou

Puncte Express: 874

Preț estimativ în valută:
11144 11649$ 9417£

Carte disponibilă

Livrare economică 13-27 februarie
Livrare express 29 ianuarie-04 februarie pentru 3203 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032699714
ISBN-10: 103269971X
Pagini: 252
Ilustrații: 34
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.45 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Public țintă

Professional Practice & Development

Cuprins

Introduction.
1. Esophageal cancer. 2. Gastric cancer. 3. Small bowel adenocarcinoma. 4. Pancreatic adenocarcinoma. 5. Hepatocellular carcinoma. 6. Biliary tract cancer. 7. Neuroendocrine neoplasms. 8. Gastro-intestinal stromal tumors. 9. Colorectal cancer. 10. Anal cancer.
Index.

Notă biografică

Giuseppe A. Colloca, MD, Oncologia Medica & Innovation, Imperia, Italy
Antonella Venturino, MD, Oncologia Medica & Innovation, Imperia, Italy

Descriere

The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.